六分钟的步骤测试可以预测COPD恶化:一个36个月的随访研究
Aldair Darlan Santos-de-Araújo1, Cássia da Luz Goulart1, Renan Shida Marinho1
1Cardiopulmonary Physiotherapy Laboratory, Universidade Federal de São Carlos, São Carlos, SP, 13565-905, Brazil.
Scientific reports
|February 13, 2024
概括
六分钟步骤测试 (6MST) 可以预测COPD患者的恶化情况. 在6MST期间爬上59个或更少的步骤表明在36个月内COPD恶化的风险更高.
科学领域:
- 肺部医学 肺部医学
- 临床运动生理学 临床运动生理学
背景情况:
- 六分钟步骤测试 (6MST) 是评估慢性阻塞性肺病 (COPD) 运动能力的有效和可访问的工具.
- 然而,它在预测COPD患者未来恶化的预后价值仍然不清楚.
研究的目的:
- 确定6MST是否可以预测COPD患者中恶化的发生.
- 使用6MST.确定恶化风险的预后值.
主要方法:
- 进行了一项前性队列研究,随访36个月.
- 64名COPD患者接受了临床评估,肺功能测试和6MST.
- 收集的数据包括爬过的台阶,心率,血压,氧气和和博格呼吸不良/疲劳得分.
主要成果:
- 与规范值相比,COPD患者的功能能力下降.
- 卡普兰-梅尔分析发现,在6MST期间登≤59个台阶是COPD恶化的重要预测因素.
- 在6MST上≤59个步骤的最低门与36个月的恶化风险增加有关.
结论:
- 6MST是COPD的有价值的预后工具.
- 在6MST上≤59个步骤的值可以识别患有未来恶化风险较高的患者.
- 这一发现有助于COPD患者的风险分层和管理.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
COPD: Management Using Bronchodilators and Corticosteroids
206
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
206
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
COPD: Pathogenesis and Clinical Features
273
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
273
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


